Expert Opinion on Pharmacotherapy

Acute respiratory distress syndrome following treatment for babesiosis
pp. 1541-1542(2)
Authors: Jr R.P.B.; Roy T.M.

Angiotensin AT-1 receptor antagonism: complementary or alternative to ACE inhibition in cardiovascular and renal disease?
pp. 1543-1556(14)
Author: Doggrell S.A.

The contentious nature of gestational diabetes: diet, insulin, glyburide and metformin
pp. 1557-1568(12)
Authors: Glueck C.J.; Goldenberg N.; Streicher P.; Wang P.

Clinical treatment regimens for chronic heart failure: a review
pp. 1569-1576(8)
Authors: Gould P.A.; Kaye D.M.

Pharmacotherapy of premenstrual syndromes and premenstrual disphoric disorder: current practices
pp. 1577-1590(14)
Authors: Mitwally M.F.; Kahn L.S.; Halbreich U.

Pharmacotherapy of hyperhomocysteinaemia in patients with thrombophilia
pp. 1591-1598(8)
Authors: O’Donnell J.; Perry D.J.

Current treatment options for acute pain
pp. 1599-1611(13)
Authors: Gottschalk A.; Wu C.L.; Ochroch E.A.

Current oral treatments for erectile dysfunction
pp. 1613-1629(17)
Authors: Kalsi J.; Cellek S.; Muneer A.; Kell P.; Ralph D.; Minhas S.

Fluvastatin
pp. 1631-1641(11)
Authors: Lawrence J.; Reckless J.

Clodronate: mechanisms of action on bone remodelling and clinical use in osteometabolic disorders
pp. 1643-1656(14)
Authors: Ghinoi V.; Brandi M.L.

The use of basiliximab in solid organ transplantation
pp. 1657-1663(7)
Authors: Henry M.L.; Rajab A.